PROLOR Biotech Inc (NYSE MKT LLC:PBTH)
Tuesday’s Trading Day
| 6.44 |  +0.03 / +0.47% |
Data as of May 21 | Day’s Change |
Wednesday’s Pre-Market Switch to standard view »
| 6.41 |  -0.03 / -0.47% |
Volume: 200.00 |
Latest PBTH News | Press Releases
| PBTH July Options Begin Trading May 20 / TheStreet.com |
Today’s Trading
| Previous close | 6.41 |
| Today’s open | 6.50 |
| Day’s range | -- - -- |
| Volume | 170,007 |
| Average volume (3 months) | 276,397 |
| Market cap | $410.1M |
| Dividend yield | -- |
Data as of 4:02pm ET, 05/21/2013
Growth & Valuation
| Earnings growth (last year) | -3.45% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 12.30 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NLNKNewLink Genetics Cor... | -0.07 | -0.44% |
| GTXIGTX Inc | +0.75 | +13.39% |
| FURXFuriex Pharmaceutica... | -0.20 | -0.51% |
| SSRX3SBio Inc | -0.02 | -0.12% |
Data as of 4:00pm ET, 05/21/2013
Financials
| Next reporting date | May 29, 2013 |
| EPS forecast (this quarter) | -$0.08 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$18.3M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer & Director Abraham Havron, PhD |
President & Director Shai A. Novik, MBA |
Corporate headquarters Nes Ziona, -- |
Forecasts
